Experimental antibodies for Parkinson’s, Alzheimer’s may cause harmful inflammation

Scientists find evidence that antibody-based treatments in clinical trials for neurodegenerative diseases may trigger an inflammatory response in human brain immune cells, eroding their positive effects.